| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |